Volpara Health, a global leader in AI-powered breast health solutions and a subsidiary of Lunit, today announced three major milestones: ...

With cancer rising in women under 40, there's concern about the causes — and the effects. Get the latest news and impactful ...

The NHS and UK doctors are set to benefit from ground-breaking artificial intelligence technology designed to transform the way doctors interact with patients, reducing medical errors, cutting ...

Biosciences, Inc. ("Anixa" or the "Company") , a biotechnology company focused on the treatment and prevention of cancer, today announced Dr. Pam Garzone, Chief Development Officer of Anixa, will be ...

Philadelphia-based Penn Medicine's Abramson Cancer Center saved its cancer patients more than 60 minutes per visit when text messaging was offered as an alternative to in-person immunotherapy ...

Riverain's CEO discusses expanding AI applications in medical imaging—from chest scans to the abdomen and beyond—and the ...

The rapid pace of innovation has made us both accept and expect continuous incremental improvements in our daily life, ranging from better appliances to lighter and more advanced phones. Progressive ...

Breast cancer is the second leading malignant disease in females worldwide. Over decades of research, breast cancer classification by molecular subtypes has ...

The global Biopsy Devices Market, valued at US$6.86 billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$7.27 billion ...

The global Biopsy Devices Market, valued at US$6.86 billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching ...

Researchers at the Arc Institute, Stanford University, and NVIDIA have developed Evo 2, an advanced AI model capable of ...